ODDB.org: Open Drug Database

Kyowa Kirin Sàrl - Poteligeo 4 mg/ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	67444	Sequence	01
Product name	Poteligeo 4 mg/ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L01XC25	ATC-Description	Mogamulizumab
Introduction of Sequence	01.09.2021

Composition

mogamulizumabum 20 mg, acidum citricum monohydricum, glycinum, polysorbatum 80, natrii hydroxidum q.s. ad pH, acidum hydrochloricum q.s. ad pH, aqua ad iniectabile ad solutionem pro 5 ml.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Mogamulizumabum	20 mg

BAG: Active Agent	Dose
Mogamulizumabum	20 mg

Inactive agents
Citric Acid Monohydrate
Glycin
Sodium Hydroxide
Polysorbatum 80

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001		1325.32	1457.80	A	SL	Yes

2025	©ywesee GmbH